Literature DB >> 30097452

Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis.

Richard Conway1,2, Lorraine O'Neill1, Geraldine M McCarthy3, Conor C Murphy4, Aurelie Fabre5, Susan Kennedy5, Douglas J Veale1, Sarah M Wade6, Ursula Fearon6, Eamonn S Molloy1.   

Abstract

OBJECTIVES: The pathogenesis of giant cell arteritis (GCA) remains unclear. TH1 and TH17 pathways are implicated, but the proximal initiators and effector cytokines are unknown. Our aim was to assess the role of interleukin 12 (IL-12) and interleukin 23 (IL-23) in GCA pathogenesis.
METHODS: IL-12 and IL-23 expression were quantified by immunohistochemistry in temporal artery biopsies (TABs). Temporal artery (TA) explant, peripheral blood mononuclear cell (PBMC) and myofibroblast outgrowth culture models were established. PBMCs and TA explants were cultured for 24 hours in the presence or absence of IL-12 (50 ng/mL) or IL-23 (10 ng/mL). Gene expression in TA was quantified by real-time PCR and cytokine secretion by ELISA. Myofibroblast outgrowths were quantified following 28-day culture.
RESULTS: Immunohistochemistry demonstrated increased expression of interleukin 12p35 (IL-12p35) and interleukin 23p19 (IL-23p19) in biopsy-positive TAs, localised to inflammatory cells. IL-12p35 TA expression was significantly increased in those with cranial ischaemic complications (p=0.026) and large vessel vasculitis (p=0.006). IL-23p19 TA expression was increased in those with two or more relapses (p=0.007). In PBMC cultures, exogenous IL-12 significantly increased interleukin 6 (IL-6) (p=0.009), interleukin 22 (IL-22) (p=0.003) and interferon γ (IFN-γ) (p=0.0001) and decreased interleukin 8 (IL-8) (p=0.0006) secretion, while exogenous IL-23 significantly increased IL-6 (p=0.029), IL-22 (p=0.001), interleukin 17A (IL-17A) (p=0.0003) and interleukin 17F (IL-17F) (p=0.012) secretion. In ex vivo TA explants, IL-23 significantly increased gene expression of IL-8 (p=0.0001) and CCL-20 (p=0.027) and protein expression of IL-6 (p=0.002) and IL-8 (p=0.004). IL-12 (p=0.0005) and IL-23 (p<0.0001) stimulation increased the quantity of myofibroblast outgrowths from TABs.
CONCLUSION: IL-12 and IL-23 play central and distinct roles in stimulating inflammatory and proliferative pathways relevant to GCA pathogenesis. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cytokines; giant cell arteritis; systemic vasculitis

Mesh:

Substances:

Year:  2018        PMID: 30097452     DOI: 10.1136/annrheumdis-2018-213488

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Cytokines, growth factors and proteases in medium and large vessel vasculitis.

Authors:  Cornelia M Weyand; Ryu Watanabe; Hui Zhang; Mitsuhiro Akiyama; Gerald J Berry; Jörg J Goronzy
Journal:  Clin Immunol       Date:  2019-02-14       Impact factor: 3.969

Review 2.  Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy
Journal:  Front Med (Lausanne)       Date:  2022-06-06

Review 3.  Highlights in clinical medicine-Giant cell arteritis, polymyalgia rheumatica and Takayasu's arteritis: pathogenic links and therapeutic implications.

Authors:  Antonio Giovanni Solimando; Angelo Vacca; Franco Dammacco
Journal:  Clin Exp Med       Date:  2021-11-06       Impact factor: 5.057

4.  Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside.

Authors:  Alessandro De Stefano; Sabrina Caporali; Nicola Di Daniele; Valentina Rovella; Carmine Cardillo; Francesca Schinzari; Marilena Minieri; Massimo Pieri; Eleonora Candi; Sergio Bernardini; Manfredi Tesauro; Alessandro Terrinoni
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 6.208

5.  Prognostic tools for hypertrophic scar formation based on fundamental differences in systemic immunity.

Authors:  Erik de Bakker; Mirthe A M van der Putten; Martijn W Heymans; Sander W Spiekstra; Taco Waaijman; Liselotte Butzelaar; Vera L Negenborn; Vivian K Beekman; Erman O Akpinar; Thomas Rustemeyer; Frank B Niessen; Susan Gibbs
Journal:  Exp Dermatol       Date:  2020-08-17       Impact factor: 3.960

6.  Human Dental Pulp Stem Cells Modulate Cytokine Production in vitro by Peripheral Blood Mononuclear Cells From Coronavirus Disease 2019 Patients.

Authors:  Stefania Croci; Martina Bonacini; Giovanni Dolci; Marco Massari; Nicola Facciolongo; Elisa Pignatti; Alessandra Pisciotta; Gianluca Carnevale; Aurelio Negro; Giulia Cassone; Francesco Muratore; Lucia Belloni; Alessandro Zerbini; Carlo Salvarani
Journal:  Front Cell Dev Biol       Date:  2021-02-05

Review 7.  The Immunopathology of Giant Cell Arteritis Across Disease Spectra.

Authors:  Michelle L Robinette; Deepak A Rao; Paul A Monach
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 8.  Biologic Therapies for Giant Cell Arteritis.

Authors:  Robert Harrington; Shamma Ahmad Al Nokhatha; Richard Conway
Journal:  Biologics       Date:  2021-01-06

9.  From Active to Non-active Giant Cell Arteritis: Longitudinal Monitoring of Patients on Glucocorticoid Therapy in Combination With Leflunomide.

Authors:  Tadeja Kuret; Mojca Frank-Bertoncelj; Katja Lakota; Polona Žigon; Gerhard G Thallinger; Andreja N Kopitar; Saša Čučnik; Matija Tomšič; Alojzija Hočevar; Snežna Sodin-Šemrl
Journal:  Front Med (Lausanne)       Date:  2022-01-20

10.  Intracerebral Hemorrhage Induced Brain Injury Is Mediated by the Interleukin-12 Receptor in Rats.

Authors:  Xuejing Yue; Lixia Liu; Haiqing Yan; Yongkun Gui; Jun Zhao; Ping Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-01       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.